Advocacy group beyond cynical on US drug pricing proposals

As Trump administration officials meet to discuss proposals affecting US drug prices, the consumer rights advocacy group Public Citizen has warned that the plans are likely to make medicines even more unaffordable.

Mick Mulvaney, director of the Office of Management and Budget, is reportedly chairing a meeting with senior government officials on the issue of prescription pricing on Friday, with those in attendance including the Health and Human Services Secretary (HHS) Tom Price, the Food and Drug Administration Commissioner Scott Gottlieb and Reed Cornish, assistant to President Donald Trump.

"The Trump administration is poised to pick price-raising policies from big pharma’s corporate wish list"